Platform

Arrakis Therapeutics is building a proprietary platform that re-architects drug discovery for RNA targets and to build a pipeline of rSMs to treat a range of diseases, including neurology, oncology and rare genetic diseases.

Arrakis’s scientific platforms enable us to identify tractable RNA targets, design drug molecules, and select candidates for clinical development to produce a pipeline of RNA-targeted small molecule medicines focused in neurology, oncology, and rare genetic disorders.

Arrakis’s platform integrates leading-edge RNA bioinformatics and structural tools, RNA-specific chemical and biological assays and traditional medicinal chemistry to identify tractable RNA targets, design drug molecules, and select candidates for clinical development.


(click to enlarge)

Back to Top